Published in Telemedicine Law Weekly, March 17th, 2007
This trend article about Massachusetts General Hospital, Boston, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Data detailed in "MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists" have been presented. "TLRs sense components of microorganisms and are critical host mediators of inflammation during infection. Different TLR agonists can profoundly alter inflammatory effects of one another, and studies suggest that the sequence of exposure to TLR agonists may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly